Make Connections to Create a Movement for Rural Health
On Thursday, September 24, the Annual Meeting of the Rural Health Philanthropy Partnership kicked off in downtown Bethesda, MD. Selected highlights from the convening’s first day setting the stage for a full day of sessions and networking opportunities centered on how collaboration can build on progress already underway in rural and tribal communities, including rural health transformation efforts.
NJ SNIP: Supporting Behavioral Health Access Through Trust-based Grantmaking
Amid shifting federal health care funding, grants that enable health care safety net entities to respond to the changing landscape can unlock immense value. This form of grantmaking puts daily program-related decisions in the hands of people doing the work, allowing organizations to develop and sustain staff positions, workflows, and programs that reflect their priorities.
Leaning Into Radical Collaboration Will Advance Your Focused Mission
At this year’s GIH annual conference, I found myself surrounded by hundreds of philanthropic leaders deeply committed to improving the health and well-being of their communities. Again and again, I met funders whose work was grounded in a particular place, population, or issue. These funders know their communities intimately. They understand local history, relationships, and the needs of their communities. Their focus is one of their greatest strengths.
Changing the Vaccine Conversation Before It’s Too Late—What Can Philanthropy Do?
In July 2026, the United States reached a grim milestone when the number of confirmed cases of measles exceeded the total for all of 2025. On August 10, 2026, the White House issued an executive order directing changes to the federal childhood vaccine schedule and categories, and calls for availability of separate measles, mumps, and rubella vaccines. The science has not changed, but the new framework could significantly slow down the delivery of protective immunizations from these serious diseases.
GIH Health Policy Update Newsletter
An Exclusive Resource for Funding Partners
The Health Policy Update is a newsletter produced in collaboration with Leavitt Partners and Trust for America’s Health. Drawing on GIH’s policy priorities outlined in our policy agenda and our strategic objective of increasing our policy and advocacy presence, the Health Policy Update provides GIH Funding Partners with a range of federal health policy news.
Philanthropy @ Work – Grants and Programs – May 2025
The latest on grants and programs from the field.
Act Now to Protect Philanthropy, Medicaid, and SNAP
Right now, Congress is finalizing a massive budget reconciliation bill that threatens philanthropy’s freedom to give and endangers the health and well-being of many millions of Americans. We are reaching out today to raise awareness of three critical developments in the ongoing budget reconciliation process and to encourage you to act.
Health and Well-Being Threatened in The First 100 Days
Statement from GIH President and CEO Cara V. James on First 100 Days
Power to the People: Advancing Impact Through Participatory Budgeting
Who is best positioned to determine how health funding should be allocated? At the Community Health Commission of Missouri (CHCM), we believe the answer is clear: the people most affected by health disparities.
Philanthropy, Stewarding a Just America
In a time of intensive action to dismantle policies and practices that protect the well-being of all Americans, where chaos is the principal strategy to overthrow the will of and care for the American people, philanthropy must remain rooted in what is legally and morally right.
How Pew Is Learning to Improve Health Policy
Antibiotics revolutionized medical treatment and are a cornerstone of modern health care. However, the global rise of antibiotic-resistant bacteria is making infections costlier and deadlier. After a 2008 report commissioned by The Pew Charitable Trusts highlighted these concerns, the organization invested in multiple projects to set limits on the use of antibiotics and to spur the development of new drugs.